Journal profile · PUBLIC, ENVIRONMENTAL & OCCUPATIONAL HEALTH
Infection Disease & Health
ISSN 2468-0451 · eISSN 2468-0869 · Australasian College for Infection Prevention and Control (ACIPC)
Infection Disease & Health: CAS Zone 3 · Medicine (2025 upgraded edition); impact factor 1.7 (journal website); hybrid open access; APC about USD 2,250; median 96 days to acceptance (90 articles, last 24 months); acceptance rate 13% (journal website); 181 articles in 2025; indexed in ESCI and Scopus.
Scope
Aims, scope and focus
Infection Disease & Health is published by Australasian College for Infection Prevention and Control (ACIPC) and is in Zone 3 of Medicine in the CAS Journal Ranking (2025 upgraded edition). By OpenAlex counts of its recent articles, its largest topics are Infection Control in Healthcare, Antibiotic Use and Resistance and Infection Control and Ventilation, together about 36.5% of its articles. (generated from OpenAlex topic counts and CAS ranking data)
Official Journal of the Australasian College for Infection Prevention and Control (ACIPC)Infection, Disease & Health (formerly Healthcare Infection) is a global platform for the publication of original knowledge that fundamentally advances the prevention and control of infection affecting human populations. The Journal welcomes submissions that relate to infection prevention and control in any of the following settings: hospitals and non-hospital healthcare settings, including community healthcareaged care child caredentistry correctional healthmental healthindigenous health and populationsindustries providing services with implications for health e.g. cosmetic and personal appearanceindustries and settings epidemiological studies related to an infection that has relevance to the healthcare environment or settings listed above. specific laboratory-based studies that focus on infection prevention and control. Examples might include transmission-based studies (engineering models for transmission pathways, sink models for AMR pathogens and or transmission pathways) as well as microbiological studies on antiseptic/disinfectant efficacyIt is important to note that all submissions must contribute new knowledge or advance debate on a relevant topic. Papers must be of relevance to the readers of Infection, Disease and Health.We accept a range of article types, including full research papers, short research reports, reviews, case reports, opinion pieces, correspondence and protocol papers. Please refer to the table in the “Author guidelines for information” about each article type, scope and various limits. We consider the following topics out of scope:treatment and/or management of infections (e.g. antimicrobial therapy for infection treatment) including the evaluation and efficacy of vaccinessurveillance or reporting of infections that are not acquired in or associated with settings described earlierarticles on vaccination with a scope relating to public or population healthantimicrobial stewardship articles related to specific clinical roles, e.g. nurse or pharmacist roles. These are better placed in discipline specific journals.articles where the primary focus is not prevention and/or control of infection.Final decisions on scope are made by the Editor-in-Chief.
From the journal's Aims & Scope
Research area (LetPub): PUBLIC, ENVIRONMENTAL & OCCUPATIONAL HEALTH
Editor-in-chief Brett MitchellPublisher website
Editorial board by country: none in mainland China; most named Australia 27, United Kingdom 6, Singapore 5, United States 2, New Zealand 2 (42 members with a country) Editorial board ↗Publisher website ·
Main research topics OpenAlex counts of recent articles; shares are approximate
- Infection Control in HealthcareMedicine20.3%
- Antibiotic Use and ResistanceImmunology and Microbiology8.8%
- Infection Control and VentilationMedicine7.5%
- Nosocomial Infections in ICUMedicine7.1%
- Medical Device Sterilization and DisinfectionImmunology and Microbiology5.5%
- Central Venous Catheters and HemodialysisHealth Professions5.3%
- Surgical site infection preventionMedicine5.1%
- Urinary Tract Infections ManagementMedicine4.2%
Rankings & indexing
CAS ranking and database indexing
CAS Journal Ranking
CAS Journal Ranking, upgraded edition (March 2025)Medicine Zone 3
| Level | Category | Zone |
|---|---|---|
| Major | Medicine | Zone 3 |
| Minor | Public, Environmental & Occupational Health | Zone 3 |
Top journal: noReview journal: no
CAS Xinrui Journal Ranking (March 2026)Medicine Zone 3
| Level | Category | Zone |
|---|---|---|
| Major | Medicine | Zone 3 |
| Minor | Public, Environmental & Occupational Health | Zone 3 |
Top journal: noReview journal: not marked
CAS Journal Ranking, previous upgraded edition (December 2023)Not covered
Not covered by this edition.
Database indexing
ESCIScopusLetPub
International journal early-warning lists: not listed in any editionLetPub
Editions, and major and minor categories, are shown separately and never merged into one zone; check which edition your institution uses before you submit or report.
Metrics
Impact metrics and publication volume
Impact
- Impact factor (publisher)
- 1.7Publisher website ·
- CiteScore 2026-06
- 3.4LetPub ·
- CiteScore (publisher)
- 3.4Publisher website ·
- SJR 2026-06
- 0.36LetPub ·
- SNIP 2026-06
- 0.57LetPub ·
- h-index
- 30OpenAlex ·
- i10-index
- 137OpenAlex ·
- 2-year mean citedness
- 0.72OpenAlex ·
- Self-citation rate
- 11.8%LetPub ·
- Share of gold OA articles
- 38.61%LetPub ·
Volume
- Articles per year
- 40LetPub ·
Articles by year OpenAlex count · 1,047 in total · the current year is incomplete
| Year | Articles | Open access | Citations |
|---|---|---|---|
| 2026 | 40 | 16 | 3 |
| 2025 | 181 | 34 | 87 |
| 2024 | 76 | 20 | 123 |
| 2023 | 68 | 40 | 191 |
| 2022 | 84 | 43 | 220 |
| 2021 | 72 | 53 | 617 |
Sources count differently and were observed at different times, so each source's own value is kept; "publisher" marks figures from the journal's website.
Review & acceptance
Review time and acceptance
Review time from article dates manuscript dates registered with PubMed · to
96 daysMedian, submission to acceptance · P25–P75 63 days – 153 days
- Acceptance to online
- median 26 days (90 articles)
- Submission to online
- median 123 days
- Sample
- 90 articles with submission and acceptance dates (110 in the window); the latest was accepted on
Only articles that were accepted and published are counted, not the time spent on rejected manuscripts, so this usually runs longer than a publisher's "time to first decision".
Other sources
- Acceptance rate (publisher)
- 13%Publisher website ·
- Submission to first decision
- 2 daysPublisher website ·
- First decision after review
- 50 daysPublisher website ·
- Submission to acceptance
- 96 daysPublisher website ·
- Peer review
- Double anonymous peer reviewPublisher website
Community reports come from authors' own submissions (confidence 0.5) and are not a promise from the journal; for publisher figures, the journal's own definitions apply.
Fees & open access
APC and open-access policy
Hybrid open accessLetPub
A subscription journal in which authors can pay to publish their article open access.
| Source | APC | Fee waiver | License | Observed |
|---|---|---|---|---|
| OpenAlex | USD 2,250 / EUR 2,100 / GBP 1,800 / JPY 279,070 | — | — | |
| Publisher website | USD 3,080 | — | — |
A hybrid journal charges the APC only when the author chooses open access; publishing under the subscription model is usually free.
The journal's website is authoritative for fees; sources were observed at different times and each keeps its own value, without averaging.
Submission
Article types and submission policies (journal website)
Open calls for papers1, by deadline
- VSI: Vascular Access DevicesDeadline
What to prepare1 items from the author guidelines
- Abstract
- ≤ 250 words
Article types accepted10
- case reportsCase reports Case reports and case series that are original, novel and interesting. This may include reporting of the management of a novel outbreak. They must …Length not stated
- correspondenceCorrespondence We welcome correspondence relating to IPC practice as well as comments relating to recently published paper in IDH that are original in nature. 8…Length not stated
- discussionDiscussion Scholarly article of a debating or discursive nature. There must be engagement with and critical analysis of a substantive body of research or other …Length not stated
- economic evaluationsEconomic evaluations Original economic evaluations of infection prevention and control trials, programs or initiatives are welcomed. 3000 30 4 CHEERLength not stated
- opinionOpinion Clear, compelling, and appeal to our readership. Papers should be well argued with new insights. 750 5Length not stated
- quality improvement papersQuality improvement papers Original contribution. If ethics is not required, provide evidence of a waiver or letter/detail from HREC indicating at the time of s…Length not stated
- research paperResearch paper Full research papers making an original contribution to the literature. 3000 3 40 4 CONSORT (RCTs); STROBE (observational); SRQR (qual)Length not stated
- review - otherReview - Other Generally not accepted. Contact the Editor-in-Chief first. 3000 40 4Length not stated
- reviews – systematic and scopingReviews – Systematic and scoping Original review that must include a repeatable search strategy consistent with recognised guidelines. 4000 50 4 PRISMALength not stated
- short research paperShort research paper This category is intended for the presentation of short, focussed research papers that make an original contribution to the literature. The…Length not stated
Policy excerpts from the journal's websiteAI use, Authorship, Conflicts of interest, License & copyright, Open access, Peer review, Preprints
- AI use Declaration of generative AI use
Authors must declare the use of generative AI tools in the manuscript preparation process upon submission of the paper.Generative AI and AI-assisted technologies (“AI tools”) have been rapidly adopted in research and scholarly publishing, offering significant benefits while requiring clear standards for responsible and transparent use.Authors preparing a manuscript for this journal may use AI tool…
Source ↗Publisher website ·- Authorship Authorship
By adhering to the authorship requirements stated above, authors meet the International Committee of Medical Journal Editors (ICMJE) criteria [updated version January 2024] on authorship.
Source ↗Publisher website ·- Conflicts of interest Declaration of competing interests
All authors must disclose any financial and personal relationships with other people or organizations that could inappropriately influence or bias their work. Examples of potential competing interests include:EmploymentConsultanciesStock ownershipHonorariaPaid expert testimonyPatent applications or registrationsGrants or any other fundingAffiliation with the journal as an Editor or Advisory Board …
Source ↗Publisher website ·- License & copyright License options
Authors will be offered open access user license options which will determine how you, and third parties, can reuse your open access article. We advise that you review these options and any funding body license requirements before selecting a license option.
Source ↗Publisher website ·- Open access Open access
We refer you to our open access information page to learn about open access options for this journal.
Source ↗Publisher website ·- Peer review Peer review
Double anonymized peer review Model summary
This journal follows a double anonymized review process. Your submission will initially be assessed by our editors. If your submission is deemed suitable, it will typically be sent to be reviewed by a minimum of two reviewers for an independent expert assessment of the scientific quality. The decision as to whether your article is accepted or rejected for publication will be made by our editors.Re…
Source ↗Publisher website ·- Preprints Preprints
Preprint sharingAuthors may share preprints in line with Elsevier's article sharing policy. Sharing preprints, such as on a preprint server, will not count as prior publication.We advise you to read our policy on multiple, redundant or concurrent publication.
Source ↗Publisher website ·
Excerpts are quoted from the journal's website; "model summary" lines are written by Workers AI and checked against the text. The journal's website is authoritative.
Profile
Publication details and official links
- Publisher
- Australasian College for Infection Prevention and Control (ACIPC)
- ISSN
- 2468-0451
- Electronic ISSN
- 2468-0869
- Society / sponsor
- Australasian College for Infection Prevention and Control
- Official links
- Journal homepage ↗LetPub
- Submission system ↗Publisher website
- Special issues ↗Publisher website
FAQ
Frequently asked questions about Infection Disease & Health
What CAS zone is Infection Disease & Health in?
In the 2025 upgraded edition of the CAS Journal Ranking, Infection Disease & Health is in Zone 3 of Medicine, and in Zone 3 of the minor category Public, Environmental & Occupational Health. In the 2026 Xinrui edition it is in Zone 3 of Medicine. Zones from different editions, and from major and minor categories, are not interchangeable.
What is the impact factor of Infection Disease & Health?
The journal's website gives an impact factor of 1.7; this is the journal's own figure, as LetPub lists none for it; CiteScore 3.4, h-index 30.
How long does peer review take at Infection Disease & Health?
Based on the dates recorded on 90 articles published between October 2024 and October 2026 (the last 24 months), the median time from submission to acceptance is 96 days (interquartile range 63–153 days); the journal's website gives an acceptance rate of 13%. Article statistics cover accepted papers only, publisher figures follow the journal's own definitions, and community reports come from authors' own submissions; none is a promise from the journal.
Where are the editorial board members of Infection Disease & Health based?
Of the 42 board members whose country the journal's board page names, none are in mainland China; the countries named most often are Australia (27), United Kingdom (6) and Singapore (5). Counted from the institutions listed on the board page; for reference only.
Which databases index Infection Disease & Health?
According to LetPub and DOAJ records, Infection Disease & Health is indexed in ESCI and Scopus.
Is Infection Disease & Health open access, and what is the APC?
Infection Disease & Health is a hybrid journal. For open-access publication: APC about USD 2,250.
Sources and updates
The facts on this page come from LetPub, Publisher website, OpenAlex; every figure is tagged with its source and the date it was observed, and conflicting values are kept per source. LetPub source page: view ↗ (archived 2026-08-25). Last updated: .